N-(3-cyclohexyl)propylphthalimide | 144290-77-7

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 异吲哚及其衍生物
• 英文名称: N-(3-cyclohexyl)propylphthalimide
• 英文别名: 2-(3-cyclohexylpropyl)isoindoline-1,3-dione；2-(3-Cyclohexylpropyl)isoindole-1,3-dione
• CAS: 144290-77-7
• 化学式: C₁₇H₂₁NO₂
• 分子量: 271.359
• InChiKey: IMTTVRRYPMFROA-UHFFFAOYSA-N

物化性质

• 沸点：
  399.7±11.0 °C(Predicted)
• 密度：
  1.134±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  4.9
• 重原子数：
  20
• 可旋转键数：
  4
• 环数：
  3.0
• sp3杂化的碳原子比例：
  0.53
• 拓扑面积：
  37.4
• 氢给体数：
  0
• 氢受体数：
  2

反应信息

• 作为反应物：
  描述：

  N-(3-cyclohexyl)propylphthalimide 在 一水合肼 作用下， 以 甲醇 为溶剂， 生成 3-环己基丙胺
  参考文献：
  名称：

  用于有机太阳能电池的环己基取代的非富勒烯小分子受体

  摘要：

  在本文中，两个环己基取代的非富勒烯小分子T2-Cy6MRH和T2-Cy6PRH被设计为具有相同的联噻吩（T2）核心和罗丹宁（RH）端基。T2-Cy6MRH和T2-Cy6PRH可以分别通过两个和四个合成步骤从市售起始原料合成。热重分析表明，两种小分子在高于380°C的温度下均具有热稳定性。与T2-Cy6PRH相比，T2-Cy6MRH表现出更高的热转变温度和更大的负焓变，表明它表现出更高的结晶度。与T2-Cy6MRH不同，T2-Cy6PRH可以通过溶液加工形成均匀的膜，因为引入更长的柔性烷基链使T2-Cy6PRH的溶解度比T2-Cy6MRH好。在T2-Cy6PRH膜（λ最大= 490纳米）显示出与小的带隙的聚合物供体PTB7钍互补UV-vis吸收（λ最大= 700纳米）。此外，与PTB7-Th相比，T2-Cy6PRH的最高占据分子轨道能级和最低未占据分子轨道能级相对较低。基于T2-Cy6PRH

  DOI：

  10.1039/d0nj04240d
• 作为产物：
  描述：

  3-环已基-1-丙醇 在 氢溴酸 作用下， 以 四氢呋喃 为溶剂， 生成 N-(3-cyclohexyl)propylphthalimide
  参考文献：
  名称：

  강심 활성을 갖는 화합물 및 이를 함유하는 심부전 예방 또는 치료용 약학적 조성물

  摘要：

  本发明揭示了具有强心活性的化合物以及含有该化合物的药学组合物，根据本发明的含有该化合物的组合物对预防和治疗心力衰竭很有用。

  公开号：

  KR20150111825A

文献信息

• Nickel/Cobalt-Catalyzed C(sp³)–C(sp³) Cross-Coupling of Alkyl Halides with Alkyl Tosylates
  作者：Kimihiro Komeyama、Takuya Michiyuki、Itaru Osaka

  DOI：10.1021/acscatal.9b03352

  日期：2019.10.4

  The C(sp3)–C(sp3) cross-coupling of alkyl halides with alkyl tosylates has been developed by employing a combination of nickel and nucleophilic cobalt catalysts in the presence of a manganese reductant. This method provides a straightforward route to a diverse set of not only secondary–primary but also primary–primary C(sp3)–C(sp3) linkages under mild conditions without using alkyl-metallic reagents

  烷基卤化物与甲苯磺酸烷基酯的C（sp 3）–C（sp 3）交叉偶联是通过在锰还原剂存在下使用镍和亲核钴催化剂的组合来开发的。这种方法为在温和条件下不使用烷基金属试剂的情况下，不仅可以实现二级（一级）连接，而且还可以一级至一级（一级）C（sp 3）-C（sp 3）连接提供了直接的途径。机理研究表明，烷基卤化物和烷基甲苯磺酸盐均可形成烷基。另外，交叉偶联可用于组蛋白脱乙酰基酶抑制剂Vorinostat的短期合成。
• Electrochemical Nickel-Catalyzed C(sp³)–C(sp³) Cross-Coupling of Alkyl Halides with Alkyl Tosylates
  作者：Malek Y. S. Ibrahim、Graham R. Cumming、Raquel Gonzalez de Vega、Pablo Garcia-Losada、Oscar de Frutos、C. Oliver Kappe、David Cantillo

  DOI：10.1021/jacs.3c07313

  日期：2023.8.9

  nickel-catalyzed, electrochemically driven method for the coupling of alkyl bromides with alkyl tosylates. Selective cross-coupling transformations were achieved even between C(sp3)-secondary bromides and tosylates. Key to achieve high selectivity was the combination of the tosylates with sodium bromide as the supporting electrolyte, gradually generating small amounts of the more reactive bromide by substitution and

  新的C(sp 3 )–C(sp 3 )键的形成是增加分子多样性的强大合成工具，这在药物化学中备受追捧。当尝试交叉偶联类似的含 C(sp 3 )反应物时，传统的碳亲核试剂生成和更现代的交叉亲电子偶联方法通常缺乏足够的选择性。在此，我们提出了一种镍催化、电化学驱动的方法，用于烷基溴与甲苯磺酸烷基酯的偶联。甚至在C(sp 3 )-仲溴化物和甲苯磺酸盐之间也实现了选择性交叉偶联转化。实现高选择性的关键是将甲苯磺酸盐与溴化钠作为支持电解质组合，通过取代逐渐产生少量更具活性的溴化物，并确保镍催化电还原过程中的反应伙伴之一在反应过程中保持过量。该过程的很大一部分。该方法已在多种底物（> 30 种化合物）中得到证实，产率中等至良好。进一步将有机电合成的范围扩大到C(sp 3 )–C(sp 3 )交叉偶联反应预计将促进向绿色有机合成的转变，并鼓励未来创新的电化学转化。
• C(sp3)–C(sp3) Coupling of Cycloalkanes and Alkyl Halides via Dual Photocatalytic Hydrogen Atom Transfer and Nickel Catalysis
  作者：Ramadevi Pilli、Keerthika Selvam、Bala S. S. Balamurugan、Vidya Jose、Ramesh Rasappan

  DOI：10.1021/acs.orglett.4c00567

  日期：2024.4.19

  Functionalization of C(sp3)–H bonds represents the most straightforward and atom-economical transformation in organic synthesis. An innovative approach integrating photocatalytic hydrogen atom transfer (HAT) and transition metal catalysis has made significant progress in the coupling of α-heterosubstituted C–H bonds with alkyl halides. However, unactivated alkanes were ineffective as a result of the

  C(sp 3 )–H 键的官能化代表了有机合成中最直接且最经济的转化。结合光催化氢原子转移（HAT）和过渡金属催化的创新方法在α-杂取代C-H键与卤代烷的偶联方面取得了重大进展。然而，由于大量副产物的形成，未活化的烷烃是无效的。在此，我们证明了环烷烃和苄基溴/伯烷基碘偶联中的直接 HAT 和镍催化作用。此外，十钨酸四丁基铵（TBADT）也被回收和再利用。
• Exploration of flexible phenylpropylurea scaffold as novel cardiac myosin activators for the treatment of systolic heart failure
  作者：Manoj Manickam、Hitesh B. Jalani、Thanigaimalai Pillaiyar、Niti Sharma、Pulla Reddy Boggu、Eeda Venkateswararao、You-Jung Lee、Eun-Seok Jeon、Sang-Hun Jung

  DOI：10.1016/j.ejmech.2017.04.005

  日期：2017.7

  A series of flexible urea derivatives have been synthesized and demonstrated as selective cardiac myosin ATPase activator. Among them 1-phenethyl-3-(3-phenylpropyl)urea (1, cardiac myosin ATPase activation at 10) mu M = 51.1%; FS = 18.90; EF = 12.15) and 1-benzyl-3-(3-phenylpropyl)urea (9, cardiac myosin ATPase activation = 53.3%; FS = 30.04; EF = 18.27) showed significant activity in vitro and in vivo. The change of phenyl ring with tetrahydropyran-4-yl moiety viz., 1-(3-phenylpropy1)-3-((tetrahydro-2H-pyran-4-y1) methyl)urea (14, cardiac myosin ATPase activation = 81.4%; FS = 20.50; EF = 13.10), and morpholine moiety viz., 1-(2-morpholinoethyl)-3-(3-phenylpropyl)urea (21, cardiac myosin ATPase activation = 44.0%; FS = 24.79; EF = 15.65), proved to be efficient to activate the cardiac myosin. The potent compounds 1, 9, 14 and 21 were found to be selective for cardiac myosin over skeletal and smooth myosins. Thus, these urea derivatives are potent scaffold to develop as a newer cardiac myosin activator for the treatment of systolic heart failure. (C) 2017 Elsevier Masson SAS. All rights reserved.
• Synthesis and histamine H2 agonistic activity of arpromidine analogues: replacement of the pheniramine-like moiety by non-heterocyclic groups
  作者：A Buschauer、A Friese-Kimmel、G Baumann、W Schunack

  DOI：10.1016/0223-5234(92)90145-q

  日期：1992.6

  Analogues of the potent histamine H-2 agonist arpromidine, characterized by non-heterocyclic groups (phenyl, cyclo-hexyl, alkyl) instead of the pheniramine-like portion, were prepared and tested for their H-2 agonistic and H-1 antagonistic activity in the isolated guinea pig right atrium and ileum, respectively. In the diphenylpropylguanidine series an increase in H-2 agonistic potency resulted from mono- or difluorination at one or both phenyl rings in the meta and/or para position (pD2 less-than-or-equal-to 7.75 vs pD2 = 7.15 for the unsubstituted parent compound). Compounds chlorinated at both phenyl rings were considerably less potent. Highest combined H-2 agonistic/H-1 antagonistic potency was found in the 4-fluorophenyl series. The arpromidine analogue with cyclohexyl and methyl group instead of phenyl and pyridine ring proved to be 30 times more potent than histamine in the atrium. The H-1 antagonistic potency in cyclohexyl compounds was lower than in the diaryl series. Thus, aromatic rings appear not to be required for high H-2 agonistic potency but are useful for combined H-2 agonistic/H-1 antagonistic activity.